Ciprofloxacin-induced cutaneous adverse drug events: a systematic review of descriptive studies

J Basic Clin Physiol Pharmacol. 2021 Mar 16;33(3):327-346. doi: 10.1515/jbcpp-2020-0115.


Objectives: Ciprofloxacin (CIPRO) is a fluroquinolone class antibiotic used commonly for the treatment of various acute and chronic bacterial infections. However, recently there is increase in the case reports of CIPRO-induced Cutaneous Adverse Drug Reactions (CADRs). We aim to systematically review all the descriptive studies of CIPRO induced CADRs.

Methods: Medline (via PubMed) was searched without any language or date restriction from inception to March 2019 using search terms of "Ciprofloxacin" and "Cutaneous reactions." We included only the descriptive studies, which elucidate the CADRs experienced by the patients following the administration of CIPRO. Two reviewers involved in study selection, data extraction and quality assessment of the included studies. Discrepancies were resolved by consensus between the reviewers.

Results: Thirty-nine studies (out of 446) were found to be eligible for the final inclusion. The dose of CIPRO among the included studies was ranging from 500 to 1,000 mg/day and duration of treatment was between 7 and 10 days. The most common CADRs observed were toxic epidermal necrolysis, Stevens-Johnson syndrome, fixed drug eruptions, bullous fixed drug reaction, acute generalized pustulosis, erythema multiforme, drug rash with eosinophilia and systemic symptoms and erythema nodosum.

Conclusions: Management of the CIPRO-induced CADRs is recommended with the complete cessation of the CIPRO, followed by supportive management with oral or topical glucocorticoids, emollients, and topical moisturizers. CIPRO is likely to cause CADRs, physicians should be vigilant while prescribing it to the patients.

Keywords: ciprofloxacin; cutaneous adverse drugs reactions; fluroquinolones; systematic review.

Publication types

  • Systematic Review

MeSH terms

  • Anti-Bacterial Agents / adverse effects
  • Ciprofloxacin / adverse effects
  • Drug Eruptions* / diagnosis
  • Drug Eruptions* / etiology
  • Drug-Related Side Effects and Adverse Reactions*
  • Humans


  • Anti-Bacterial Agents
  • Ciprofloxacin